Sarepta Therapeutics Overview
Sarepta Therapeutics Target Price
Analysts' 12-month price predictions for SRPT.
Share Price
$17.1
Average Target Price
$57.00
233.3% upside
233.3% upside5 analysts in the last 4 months
High: $110 | Low: $10
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-06-25 | H.C. Wainwright | $10 |  41.5% downside |  |
| 2025-06-17 | Wells FargoYanan Zhu | $75 | 338.6% upside | |
| 2025-06-16 | Cantor FitzgeraldKristen Kluska | $20 | 17% upside | |
| 2025-06-15 | BMO CapitalKostas Biliouris | $70 | 309.4% upside | |
| 2025-04-21 | Piper Sandler | $110 | 543.3% upside | |
| 2024-11-27 | NeedhamGil Blum | $202 | 1081.3% upside | |
| 2024-11-27 | Piper SandlerBiren Amin | $182 | 964.3% upside | |
| 2024-11-07 | Cantor FitzgeraldKristen Kluska | $167 | 876.6% upside | |
| 2024-11-07 | Robert W. BairdBrian Skorney | $193 | 1028.7% upside | |
| 2024-10-21 | JefferiesAndrew Tsai | $165 | 864.9% upside | |
| 2024-08-08 | RBC CapitalBrian Abrahams | $181 | 958.5% upside | |
| 2024-08-08 | Evercore ISIGavin Clark-Gartner | $179 | 946.8% upside | |
| 2024-08-08 | Piper SandlerBiren Amin | $200 | 1069.6% upside | |
| 2024-08-08 | BarclaysGena Wang | $203 | 1087.1% upside | |
| 2024-07-29 | RBC CapitalBrian Abrahams | $182 | 964.3% upside | |
| 2024-06-27 | BMO CapitalKostas Biliouris | $200 | 1069.6% upside | |
| 2024-06-26 | Piper SandlerBiren Amin | $205 | 1098.8% upside | |
| 2024-06-24 | Evercore ISIGavin Clark-Gartner | $185 | 981.9% upside | |
| 2024-06-24 | Mizuho SecuritiesUy Ear | $200 | 1069.6% upside | |
| 2024-06-21 | Robert W. BairdBrian Skorney | $200 | 1069.6% upside | |
| 2024-06-13 | Robert W. BairdBrian Skorney | $170 | 894.2% upside | |
| 2024-06-13 | Piper SandlerBiren Amin | $157 | 818.1% upside | |
| 2024-06-13 | BarclaysGena Wang | $185 | 981.9% upside | |
| 2024-06-07 | BMO CapitalKostas Biliouris | $170 | 894.2% upside | |
| 2024-05-28 | RBC CapitalBrian Abrahams | $142 | 730.4% upside | |
| 2024-05-20 | RBC CapitalBrian Abrahams | $157 | 818.1% upside | |
| 2024-05-17 | Mizuho SecuritiesUy Ear | $179 | 946.8% upside | |
| 2024-05-14 | OppenheimerHartaj Singh | $180 | 952.6% upside | |
| 2024-05-06 | Morgan StanleyMatthew Harrison | $165 | 864.9% upside | |
| 2024-05-02 | RBC CapitalBrian Abrahams | $141 | 724.6% upside | |
| 2023-03-01 | Morgan StanleyMatthew Harrison | $187 | 993.6% upside | |
| 2023-01-10 | Credit Suisse | $114 | 566.7% upside | |
| 2023-01-10 | Needham | $160 | 835.7% upside | |
| 2022-12-22 | BTIG | $160 | 835.7% upside | |
| 2022-12-16 | UBS | $158 | 824% upside | |
| 2022-11-03 | NeedhamGil Blum | $158 | 824% upside | |
| 2022-09-08 | Morgan Stanley | $135 | 689.5% upside | |
| 2022-08-15 | OppenheimerHartaj Singh | $150 | 777.2% upside | |
| 2022-08-03 | Morgan Stanley | $100 | 484.8% upside | |
| 2022-07-29 | Needham | $162 | 847.4% upside | |
| 2022-07-15 | Morgan Stanley | $80 | 367.8% upside | |
| 2022-05-24 | Goldman Sachs | $155 | 806.4% upside | |
| 2022-03-02 | Berenberg BankZhiqiang Shu | $94 | 449.7% upside | |
| 2022-03-02 | NeedhamGil Blum | $150 | 777.2% upside | |
| 2022-01-10 | Mizuho SecuritiesUy Ear | $160 | 835.7% upside | |
| 2022-01-05 | BTIGYun Zhong | $125 | 631% upside | |
| 2022-01-04 | OppenheimerHartaj Singh | $125 | 631% upside | |
| 2021-10-15 | Credit SuisseJudah Frommer | $95 | 455.6% upside | |